Find or Sell Used Cars, Trucks, and SUVs in USA

1955 Chrysler New Yorker Deluxe Hardtop on 2040-cars

US $45,000.00
Year:1955 Mileage:72587 Color: Tan /
 Coral
Location:

Advertising:
Vehicle Title:--
Engine:331 ci Hemi
Fuel Type:Gasoline
Body Type:Hardtop
Transmission:Automatic
For Sale By:Dealer
Year: 1955
VIN (Vehicle Identification Number): N5541704
Mileage: 72587
Make: Chrysler
Trim: Deluxe Hardtop
Features: --
Power Options: --
Exterior Color: Tan
Interior Color: Coral
Warranty: Unspecified
Model: New Yorker
Condition: Used: A vehicle is considered used if it has been registered and issued a title. Used vehicles have had at least one previous owner. The condition of the exterior, interior and engine can vary depending on the vehicle's history. See the seller's listing for full details and description of any imperfections. See all condition definitions

Auto blog

Chrysler 100, midsize CUV and plug-in hybrid minivan launch bid to go mainstream

Tue, 06 May 2014

The news just keeps on rolling from Auburn Hills today, as Fiat Chrysler continues to detail its five-year growth plan. This time round, we're talking about Chrysler. The troubled American brand has been limited in the past few years to the lamentable Sebring/200, the Town & Country and the 300, although that's likely to change in the coming years.
"The Chrysler brand is not luxury - it's not premium. Chrysler is the mainstream American brand," brand CEO Al Gardner said during today's presentation.
Gardner set a sales target of 800,000 units by 2018, which marks an increase of 350,000 units compared to its 2013 sales results. That's a pretty big ask for a brand that's struggled to define itself over the past decade.

Junkyard Gem: 1990 Plymouth Laser RS Turbo

Mon, Jul 3 2017

When Diamond Star Motors, a Chrysler-Mitsubishi joint venture, came online in the late 1980s, the first products to come out of the Normal, Illinois assembly plant were versions of the first-generation of the Mitsubishi Eclipse. There was the Eclipse itself, the Eagle Talon, and the Plymouth Laser. Here's a somewhat tattered example of the latter type, spotted in a Northern California self-serve yard. This car is unrelated to the Chrysler Laser of a few years earlier, which was based on the K-platform-derived Dodge Daytona. The Plymouth Laser was a pure Mitsubishi design. This one has the DOHC turbocharged 2.0-liter Sirius engine, rated at 190 horsepower. That was plenty of power by 1990 standards, a year in which the wildest possible Chevrolet Camaro (the IROC-Z, of course) packed just 230 hp under the hood. The IROC-Z weighed 3,149 pounds versus the Laser's 2,483, giving the Laser a slightly better power-to-weight ratio, not to mention a price tag more than $500 lower. CD players in cars were still uncommon in 1990; this Laser has the much more mainstream "computer controlled deck" cassette player, complete with nine-band graphic equalizer. Badging in futuristic typefaces was all the rage when this car was new. The all-wheel-drive Eclipse/Talon/Laser didn't hit dealerships until the 1991 model year, so all the '90s are front-wheel-drive only. The torque steer experienced in these cars could be exciting. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. In the United States, Tina Turner pitched the Laser. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. North of the border, Celine Dion did the Laser's TV ads. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. In Japan, the 1990 Eclipse featured "international breeze," whatever that is. Featured Gallery Junked 1990 Plymouth Laser RS Turbo View 23 Photos Auto News Chrysler Mitsubishi mitsubishi eclipse

Fiat Chrysler says it did not know about Marchionne's illness

Fri, Jul 27 2018

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.